We have changed our visitation policy for the safety of our patients and staff. Click here for the updated visitation policy and click here for information about COVID-19.

[LCID Study Number: 2018-056]

PERSPECTIVE-LCZ696/Entresto: A Multicenter, randomized, double-blind, active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction

This study is to evaluate the effects of the study drug LCZ696 on cognitive function in patients with chronic heart failure and preserved ejection fraction

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2412